Urologix Odds of Future Pink Sheet Price Finishing Over 1.0E-4
| ULGXDelisted Stock | USD 0.0001 0.00 0.00% |
Urologix |
Urologix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Urologix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Urologix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Urologix is not yet fully synchronised with the market data | |
| Urologix has some characteristics of a very speculative penny stock | |
| Urologix has a very high chance of going through financial distress in the upcoming years | |
| Urologix currently holds 4.59 M in liabilities. Urologix has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Urologix until it has trouble settling it off, either with new capital or with free cash flow. So, Urologix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Urologix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Urologix to invest in growth at high rates of return. When we think about Urologix's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.01 M. Net Loss for the year was (7.61 M) with profit before overhead, payroll, taxes, and interest of 5.9 M. | |
| Urologix currently holds about 492 K in cash with (1.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Urologix Technical Analysis
Urologix's future price can be derived by breaking down and analyzing its technical indicators over time. Urologix Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Urologix. In general, you should focus on analyzing Urologix Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Urologix Predictive Forecast Models
Urologix's time-series forecasting models is one of many Urologix's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Urologix's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Urologix
Checking the ongoing alerts about Urologix for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Urologix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Urologix is not yet fully synchronised with the market data | |
| Urologix has some characteristics of a very speculative penny stock | |
| Urologix has a very high chance of going through financial distress in the upcoming years | |
| Urologix currently holds 4.59 M in liabilities. Urologix has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Urologix until it has trouble settling it off, either with new capital or with free cash flow. So, Urologix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Urologix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Urologix to invest in growth at high rates of return. When we think about Urologix's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 14.01 M. Net Loss for the year was (7.61 M) with profit before overhead, payroll, taxes, and interest of 5.9 M. | |
| Urologix currently holds about 492 K in cash with (1.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Urologix Pink Sheet
If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |